The qPCR analysis revealed increases in the expression of TP53 in peripheral blood lymphocytes from melanoma patients compared to healthy donors following treatment with 1.2, 0.5 and 0.2 mW/cm2 (Fig. 4). The gene discussed is TP53; the disease is melanoma.